Related Experiment Video
Updated: May 21, 2025
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Silencing hnRNPD inhibits gastric cancer growth by increasing TXNIP-mediated oxidative stress
Xuan Zou1,2, Jin Li1,2, Junshuo Zhou3
1Reproductive Medicine Center, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China.
Background:
RNA-binding proteins (RBPs) are essential for controlling gene expression, and their dysregulation is a key factor in tumor development and progression. Heterogeneous nuclear ribonucleoprotein D (hnRNPD), a member of the hnRNP family of RBPs, is aberrantly expressed in various tumors. However, its role and underlying mechanisms in gastric cancer have not been determined.
Methods:
The expression patterns of hnRNPD in gastric cancer were analyzed using publicly available datasets and clinical specimens. The effects of hnRNPD on gastric cancer cell growth were assessed using the Cell Counting Kit-8 (CCK-8) and colony formation assays. Target genes regulated by hnRNPD were identified through RNA sequencing (RNA-seq) and RNA immunoprecipitation sequencing (RIP-seq).
Results:
Elevated expression of hnRNPD was observed in gastric cancer, and this overexpression was associated with an unfavorable prognosis. Knocking down hnRNPD could suppress the growth of gastric cancer cells and enhance endogenous oxidative stress. Thioredoxin-interacting protein (TXNIP) was identified as a downstream target of hnRNPD. Further analysis confirmed that hnRNPD diminished TXNIP expression by binding to and destabilizing its mRNA. Moreover, silencing TXNIP reversed the decrease in cell growth and the increase in oxidative stress caused by hnRNPD knockdown.
Conclusion:
Our study highlights hnRNPD as a major contributor to gastric carcinogenesis. The knockdown of hnRNPD hinders gastric cancer growth by directly interacting with TXNIP, promoting its expression, and inducing oxidative stress. These findings suggest that hnRNPD may serve as a valuable target for the treatment of gastric cancer.
Insights
Heterogeneous nuclear ribonucleoprotein D (hnRNPD) drives gastric cancer by suppressing TXNIP and oxidative stress. Reducing hnRNPD inhibits tumor growth, suggesting it as a potential therapeutic target for gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- RNA-binding proteins (RBPs) regulate gene expression; their dysregulation contributes to cancer.
- Heterogeneous nuclear ribonucleoprotein D (hnRNPD) is aberrantly expressed in tumors, but its role in gastric cancer is unclear.
Purpose of the Study:
- To investigate the role and molecular mechanisms of hnRNPD in gastric cancer development and progression.
Main Methods:
- Analyzed hnRNPD expression in gastric cancer datasets and specimens.
- Assessed hnRNPD's impact on cell growth using CCK-8 and colony formation assays.
- Identified hnRNPD targets via RNA sequencing and RNA immunoprecipitation sequencing.
Main Results:
- hnRNPD was overexpressed in gastric cancer, correlating with poor prognosis.
- hnRNPD knockdown suppressed tumor growth and increased oxidative stress.
- hnRNPD directly targets TXNIP, reducing its expression by destabilizing mRNA; TXNIP silencing reversed the effects of hnRNPD knockdown.
Conclusions:
- hnRNPD promotes gastric carcinogenesis by downregulating TXNIP and inhibiting oxidative stress.
- Targeting hnRNPD offers a potential therapeutic strategy for gastric cancer treatment.
Related Concept Videos
02:23Abnormal Proliferation
02:15Experimental RNAi
01:22MicroRNAs
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:55The Nucleolus
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...